Pfizer Limited (PFIZER)
ISIN: - Industry: Drug Manufacturers—General Sector: Healthcare Website
4101.7
-8.15(-0.2%)

Pfizer Limited manufactures, markets, trades in, and exports pharmaceutical products in India and internationally. It offers its products in various therapeutic areas, including anti-allergic, anti-diabetic, antihistamine, anti-infective, anti-parasitic, cardiovascular, dermatology, erectile dysfunction, neurology, pain/fever/inflammation, pediatrics, psychiatry, respiratory, urology, women's health, central nervous system, autoimmune disorders, and gastrointestinal, as well as opthalmology and antiparasitic. The company also provides multivitamins, vitamins/minerals, antibiotics, steroids, and vaccines. It sells its products through a network of independent distributors primarily under various brand names. The company was incorporated in 1950 and is headquartered in Mumbai, India.

Pricing Updates

TODAY'S HIGH

4113.8

TODAY'S LOW

4079.5

52 WEEK HIGH

6175

52 WEEK LOW

4060

Major Holders

% of Shares Held by
All Insider

66.77%

% of Shares Held by
Institutions

15.38%

% of Float Held by
Institutions

46.29%

Number of Institutions
Holding Shares

30

Company Overview

MARKET CAP

18764.33 Cr.

ETERPRISE VALUE

17332.86 Cr.

NO. OF SHARES

4.57 Cr.

BOOK VALUE

626.213

DIV. YIELD

5%

DEBT

166.99 Cr.

GROSS PROFIT

1662.96 Cr.

CASH

1633.32 Cr.

REVENUE

2610.99 Cr.

REVENUE/SHARE

570.696

OHLC Chart 1y 2y 5y 10y

Price Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Volumes Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Cashflows

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Investments-612.50 Cr.-501.99 Cr.1384.27 Cr.-119.40 Cr.
Change To Liabilities-11.19 Cr.-140.93 Cr.3.22 Cr.-59.10 Cr.
Total cashflows from Investing Activities-575.02 Cr.-468.84 Cr.1530.32 Cr.35.12 Cr.
Net Borrowings-19.99 Cr.-49.09 Cr.-39 Cr.-39 Cr.
Total Cash from Financing Activities-180.51 Cr.-1571.07 Cr.-163.52 Cr.-109.85 Cr.
Other Liabilities87.34 Cr.10.75 Cr.-9.29 Cr.-75.91 Cr.
Total Assets0000
Net Income612.56 Cr.497.61 Cr.509.13 Cr.429.05 Cr.
Change in Cash-88.45 Cr.-1612.58 Cr.1689.98 Cr.23.08 Cr.
Effect of Exchange Rate0000
Total Cash from Operating Activities667.08 Cr.427.33 Cr.323.18 Cr.97.81 Cr.
Depreciation115 Cr.107.23 Cr.101.06 Cr.69.21 Cr.
Other Cashflows from Investing Activities50.73 Cr.50.77 Cr.147.87 Cr.127.65 Cr.
Dividends Paid-159.74 Cr.-99.81 Cr.-102.93 Cr.-91.05 Cr.
Change to Inventory-13.86 Cr.-4.46 Cr.-43.93 Cr.-90.82 Cr.
Change to Account Receivables-18.91 Cr.42.86 Cr.-2.46 Cr.-19.24 Cr.
Other Cashflows from Financing Activities-78 Lakhs-2.63 Cr.-21.59 Cr.-18.80 Cr.
Change to Net Income-103.86 Cr.-87.91 Cr.-236.73 Cr.-157.56 Cr.
Capital Expenditures-15.31 Cr.-17.70 Cr.-38.39 Cr.-4.49 Cr.

Financials

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Research DevelopmentNoneNoneNoneNone
Effect of Accounting ChargesNoneNoneNoneNone
Income Before Tax772.89 Cr.668.72 Cr.642.49 Cr.659.91 Cr.
Minority InterestNoneNoneNoneNone
Net Income720.73 Cr.609.62 Cr.481.27 Cr.502.65 Cr.
Selling General Administrative403.67 Cr.426.84 Cr.453.12 Cr.441.55 Cr.
Gross Profit1662.96 Cr.1435.75 Cr.1353.23 Cr.1328.26 Cr.
Ebit720.73 Cr.609.62 Cr.481.27 Cr.502.65 Cr.
Operating Income720.73 Cr.609.62 Cr.481.27 Cr.502.65 Cr.
Other Operating Expenses423.56 Cr.290.14 Cr.315.86 Cr.312.94 Cr.
Interest Expense-10.49 Cr.-15.11 Cr.-10.85 Cr.-1.29 Cr.
Extraordinary ItemsNoneNoneNoneNone
Non RecurringNoneNoneNoneNone
Other ItemsNoneNoneNoneNone
Income Tax Expense160.33 Cr.171.11 Cr.133.36 Cr.230.86 Cr.
Total Revenue2610.99 Cr.2238.55 Cr.2151.65 Cr.2081.50 Cr.
Total Operating Expenses1890.26 Cr.1628.93 Cr.1670.38 Cr.1578.85 Cr.
Cost of Revenue948.03 Cr.802.80 Cr.798.42 Cr.753.24 Cr.
Total Other Income Expense Net52.16 Cr.59.10 Cr.161.22 Cr.157.26 Cr.
Discontinued OperationsNoneNoneNoneNone
Net Income from Continuous Ops.612.56 Cr.497.61 Cr.509.13 Cr.429.05 Cr.
Net Income Applicable to Common Shares612.56 Cr.497.61 Cr.509.13 Cr.429.05 Cr.

Balance Sheet

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Intangible Assets94.55 Cr.144.87 Cr.199.90 Cr.254.94 Cr.
Capital Surplus01320.67 Cr.1320.67 Cr.1320.67 Cr.
Total Liabilities1036.10 Cr.872.86 Cr.1009.91 Cr.928.65 Cr.
Stock Holder Equity2864.41 Cr.2393.04 Cr.3395.49 Cr.3011.34 Cr.
Minority Interest0000
Other Liabilities549.70 Cr.323.04 Cr.323.29 Cr.378.54 Cr.
Total Assets3900.51 Cr.3265.90 Cr.4405.40 Cr.3939.99 Cr.
Common Stock45.75 Cr.45.75 Cr.45.75 Cr.45.75 Cr.
Retained Earnings0982.95 Cr.1995 Cr.1609.96 Cr.
Other Liabilities55.47 Cr.55.84 Cr.47.87 Cr.36.96 Cr.
Good Will527.49 Cr.527.49 Cr.527.49 Cr.527.49 Cr.
Treasury Stock2818.66 Cr.43.67 Cr.34.07 Cr.34.96 Cr.
Other Assets661.92 Cr.473.69 Cr.414.48 Cr.370.77 Cr.
Cash1633.33 Cr.157.03 Cr.1763.79 Cr.73.81 Cr.
Current Liabilities852.89 Cr.774.34 Cr.873.36 Cr.891.69 Cr.
Long Term Asset Charges45.98 Cr.13.46 Cr.62 Lakhs0
Short Long Term Debt2.50 Cr.2.50 Cr.2.50 Cr.2.50 Cr.
Other Stockholder Equity2818.66 Cr.43.67 Cr.34.07 Cr.34.96 Cr.
Property Plant Equipment220.07 Cr.195.14 Cr.215.28 Cr.71.43 Cr.
Total Cur. Assets2396.48 Cr.1924.71 Cr.3048.25 Cr.2715.36 Cr.
Long Term Investments0000
Net Tangible Assets2242.37 Cr.1720.68 Cr.2668.10 Cr.2228.91 Cr.
Short Term Investments0941 Cr.431 Cr.1818 Cr.
Net Receivables180.03 Cr.308.21 Cr.330.69 Cr.349.46 Cr.
Long Term Debt0000
Inventory448.90 Cr.435.05 Cr.430.59 Cr.386.66 Cr.
Accounts Payable263.94 Cr.283.74 Cr.426.78 Cr.435.92 Cr.

New Offers


Upstox offer
Upstox

Open a demat account through us and get the account opening charges waived off

open paperless account